참고문헌
- Arai T, Akita S, Sakon M, et al (2014). Hepatocellular carcinoma associated with sarcoidosis. Int J Surg Case Rep, 5, 562-5. https://doi.org/10.1016/j.ijscr.2014.06.018
- Bagi CM, Gebhard DF, Andresen CJ (2012). Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models ofhepatocellular carcinoma. Eur J Gastroenterol Hepatol, 24, 563-74. https://doi.org/10.1097/MEG.0b013e328350916f
- Cheng XP, Zhang ZW (2009). Surgical treatment strategy of large and huge hepatocellular carcinoma. Chin J Operative Proced General Surg, 3, 702-6.
- Chow KC, Tang CN, Lai EC, et al (2013). Curative treatment for recurrent tumour implantation after ruptured hepatocellular carcinoma. Hong Kong Med J, 19, 82-4.
- Graf D, Vallbohmer D, Knoefel WT, et al (2014). Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med, 25, 430-7. https://doi.org/10.1016/j.ejim.2014.03.001
- Hironori K, Masaru T, Yuichiro O, et al (2008). Laparoscopyassisted hepatectomy for giant hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech, 18, 127-31. https://doi.org/10.1097/SLE.0b013e318158237b
- Jin YJ, Lee JW, Choi YJ, et al (2014). Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg, 18, 555-61. https://doi.org/10.1007/s11605-013-2440-x
- Joshita S, Yoshizawa K, Sano K, et al (2010). A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med, 49, 991-4. https://doi.org/10.2169/internalmedicine.49.3153
- Li GH, Hong ZX, Zhang KM (2012). Surgical treatment of huge hepatocellular carcinoma. J Mod Oncol, 20, 1495- 7.
- Li SH, Guo ZX, Xiao CZ, et al (2013). Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev, 14, 4759-63. https://doi.org/10.7314/APJCP.2013.14.8.4759
- Li SL, Su M, Peng T, et al (2013). Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 14, 217-23. https://doi.org/10.7314/APJCP.2013.14.1.217
- Maida M, Orlando E, Camma C, et al (2014). Staging systems of hepatocellular carcinoma: areviewofliterature. World J Gastroenterol, 20, 4141-50. https://doi.org/10.3748/wjg.v20.i15.4141
- Que JY, Lin LC, Lin KL, et al (2014). The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities. Radiat Oncol, 9, 120. https://doi.org/10.1186/1748-717X-9-120
- Ren YQ, Han JQ, Cao JB, et al (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4. https://doi.org/10.7314/APJCP.2012.13.11.5451
- Scaggiante B, Kazemi M, Pozzato G, et al (2014). Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol, 20, 1268-88. https://doi.org/10.3748/wjg.v20.i5.1268
- Shin YJ, Kim MS, Yoo SY, et al (2010). Pilot study of stereotactic body radiotherapy for huge hepatocellular carcinoma unsuitable for other therapies. Tumori, 96, 65-70.
- Tsoulfas G, Mekras A, Agorastou P, et al (2012). Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J Surg, 82, 510-7. https://doi.org/10.1111/j.1445-2197.2012.06079.x
- Wang ZJ, Wang MQ, Duan F, et al (2013). Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 1649-54. https://doi.org/10.7314/APJCP.2013.14.3.1649
-
Yang J, Li C, Wen TF, et al (2014). Is hepatectomy for huge hepatocellular carcinoma (
${\geq}$ 10cm in diameter) safe and effective? A single-center experience. Asian Pac J Cancer Prev, 15, 7069-77. https://doi.org/10.7314/APJCP.2014.15.17.7069 - Yang L, Xu J, Ou D, et al (2013). Hepatectomy for Huge Hepatocellular Carcinoma: Single Institutes Experience. World J Surg, 37, 2189-96. https://doi.org/10.1007/s00268-013-2095-5
- Yang LY, Fang F, Yang H (2010). Surgical resection of solitary huge hepatocellular carcinoma. Chin J Pract Surg, 30, 662-4.
-
Yamashita Y, Taketomi A, Shirabe K, et al (2011). Outcomes of hepatic resection for huge hepatocellularcarcinoma (
${\geq}$ 10cm in diameter). J Surg Oncol, 104, 292-8. https://doi.org/10.1002/jso.21931 - Zhang Y, Zhang WL, Huang DS, et al (2013). Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study. Asian Pac J Cancer Prev, 14, 4583-9. https://doi.org/10.7314/APJCP.2013.14.8.4583
-
Zhong NB, Lv GM, Chen ZH (2014). Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (
${\geq}$ 10 cm)hepatocellular carcinomas: A clinical study. Mol Clin Oncol, 2, 839-844. - Zhang ZW, Cheng XP (2008). Techniques for large hepatic resection. J Hepatobil Surg, 16, 6-7.
피인용 문헌
- Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0717-0
- Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5541
- Plasma Nuclear Factor Kappa B and Serum Peroxiredoxin 3 in Early Diagnosis of Hepatocellular Carcinoma vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1657
- The High Expressed Serum Soluble Neural Cell Adhesion Molecule, a High Risk Factor Indicating Hepatic Encephalopathy in Hepatocelular Carcinoma Patients vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3131
- Risk factors for the Long-Term Efficacy, Recurrence, and Metastasis in Small Hepatocellular Carcinomas vol.72, pp.2, 2015, https://doi.org/10.1007/s12013-015-0514-y
- Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells vol.15, pp.5, 2016, https://doi.org/10.1021/acs.jproteome.5b01125
- Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.473